BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 55 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 55 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT

Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On a GAAP basis, the company reported a net income of $594 million, or $0.10 per share, compared to a loss of $337 million, or $0.06 per share, last year. Adjusted net income increased 15% to […]

$PFE February 2, 2021 1 min read

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today.

Revenues increased 12% year-over-year to $11.7 billion.

On a GAAP basis, the company reported a net income of $594 million, or $0.10 per share, compared to a loss of $337 million, or $0.06 per share, last year.

Adjusted net income increased 15% to $2.3 billion while adjusted EPS rose 14% to $0.42.

For the full year of 2021, revenues are expected to be $59.4-61.4 billion while adjusted EPS guidance was raised to a range of $3.10-3.20 from the previous range of $3.00-3.10.

ADVERTISEMENT

Prior performance

Pfizer Q3 2020 earnings
ADVERTISEMENT